XAF-1, a diagnostic marker for interferon responsiveness in multiple sclerosis
Details for Australian Patent Application No. 2007222852 (hide)
International Classifications
Event Publications
28 August 2008 PCT application entered the National Phase
PCT publication WO2007/101341 Priority application(s): WO2007/101341
11 December 2008 Alteration of Name
The name of the applicant has been altered to Aegera Therapeutics, Inc.; The Children's Hospital of Eastern Ontario
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser